• Execute prospective and retrospective epidemiology studies in the pre-launch and post-launch setting, utilizing real world data (RWD) to explore disease patterns and outcomes• Partner with data science and biostatistics team to develop statistical analysis plans (SAPs) driven by study protocols that range from descriptive to complex methodologies• Conduct critical review of real world evidence (RWE) and epidemiology studies designed by internal teams and/or external partners to ensure scientific robustness and strategic alignment• Generate standardized codes or bucket code lists for utilization in claims and EHR data sources to support streamlining of projects and research efforts, reducing concept timelines by 1-2 weeks• Develop and adopt robust, fit-for-purpose data generation and analytic methodologies utilizing RWD from EHR, claims, patient charts, and registries• Support data analyses of RWD sources with internal data science and external data partners, exhibiting effective communication and management skills• Ensure the fulfillment of epidemiology sections in regulatory documents such as submissions, RMPs, FDA diversity analysis, advisory committee briefings, etc.• Develop integrated evidence generation plans (IEGPs) and identify strategies to address prioritized evidence gaps that contribute to the global integrated data and evidence vision at Ipsen• Represent 4 indications during IEGP development, prioritizing value to payers, population health decision makers, health care providers (HCPs), and patients• Conduct systematic and targeted literature reviews (SLRs and TLRs) to support decision making for business development, forecasting, medical, and epidemiology• Conduct feasibility assessment of relevant data sources to critically evaluate the potential for use with rare disease assets• Communicate data and insights gathered from external experts, including HCPs and patient organizations

• Designed targeted retrospective studies, overseeing statistical analysis plans (SAPs), managing 8-10 cross-functional team members, co-authoring 2 studies• Organized oncology studies through feasibility, conceptualization, and protocol development, demonstrating expertise in endpoint strategy, value differentiation, and statistical analysis• Analyzed electronic health record (EHR), claims, and registry data with hands-on experience around leading data providers such as Flatiron, Optum, IQVIA, and more • Responsible for pro-actively implementing health outcomes strategies, supporting drug development, product life cycle, and trial data interpretation• Supported product submissions to regulatory and HTA bodies, authoring and publishing materials to congresses as well as reviewing value dossiers• Co-authored a systematic literature review (SLR) utilizing PRISMA method, negotiating vendor proposals to manage budget and timeline, efficiently reducing project cost by 13%• Created and oversaw RWD provider database assessing strengths, weaknesses, and capabilities of more than 70 US and global providers, reducing surveying efforts by 72% across the business• Engaged and maintained relationships with data providers and scientific stakeholders, with a network built to leverage HCP interactions and collaborate on research opportunities• Managed RWD Center of Excellence team initiatives focused on data capabilities, having supported the launch of a federated governance structure within a matrix environment• Identified and recruited KOLs for advisory boards to help define global data strategy

• Walgreens Pharmacy on Golf rd and Barrington rd, Hoffman Estates, IL. Pharmacy Manager: Dr. Michelle Leung, PharmD. Provided customer service, counted medication, PCQ calls, and other tasks that encompass the role of a Pharmacy Technician.

• Conducted real world research on physician prescribing habits of opioid medications within the Illinois health networks utilizing electronic medical record (EMR) academically licensed data• Co-lead literature review and SWOT analysis of covid vaccine, developing guidance materials for local health systems, increasing transparency of information, and raising negotiating power for improved patient access• Utilized SAS and Excel macros to run data analysis for 3 projects

• Orchestrated internal analysis for MSL education material, collecting resource needs across field teams and integrating them into US and global slide decks, resulting in a 20% increase of education content• Spearheaded a discrepancy identification initiative, correcting over 75 differences, and the merging of melanoma global and US reactive decks to provide a singular point of truth for MSLs• Educated cross-functions on precision medicine, precision therapy outcomes in oncology, and valuable biomarkers